Novo Nordisk invests €2.34B to expand its Anagni facility near Rome, enhancing production of diabetes and obesity treatments ...

Merck (MSD outside US & Canada) announces $10B acquisition of Verona Pharma to enhance its respiratory portfolio with COPD ...

Black Book Flash Poll Reveals Serious Concerns About Workforce Instability and Care Disruptions Across Hospitals, Nursing Homes, and Long-Term Care Facilities NEW YORK CITY, NEW YORK / ACCESS Newswire ...

Winner of the DEXIS IS 3800W Intraoral Scanner to Be Revealed This August QUAKERTOWN, PENNSYLVANIA / ACCESS Newswire / July 9, 2025 / DEXIS™, a global leader in dental imaging innovation, announces ...

MESA, ARIZONA / ACCESS Newswire / July 9, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) is advancing a powerful multi-sector strategy focused on three explosive industries: AI-powered digital ...

HOUSTON, TX / ACCESS Newswire / July 9, 2025 / Mann Eye Institute, a leader in innovative eye care since the 1970s, is proud to announce the addition of the LumiThera Valeda Light Delivery System to ...

HOUSTON, TX / ACCESS Newswire / July 9, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for ...

LOS ANGELES, CA / ACCESS Newswire / July 9, 2025 / HRC Fertility is proud to announce its participation in a groundbreaking clinical trial evaluating Fertilo, an investigational approach to in vitro ...

LOS ANGELES, CA / ACCESS Newswire / July 9, 2025 / Renovaro Inc. (NASDAQ:RENB), an AI-driven precision medicine company, today announced that senior debt holders have agreed to convert an aggregate of ...

Innovation in pharmaceutical secondary packaging is so much more than a competitive advantage – in today’s market, it is a ...

Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces today thar it has received a Notice ...

New data reveals sponsors risk wasting billions by designing overly complex trials and repeatedly recruiting from oversaturated investigator sites Boston, US. 9 July, 2025. Dr. Gen Li, CEO of Phesi, a ...